- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Peking University Health Science Center Hospital
I alt 5953 resultater
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuSlimhinde melanom | Neoadjuverende behandlingKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringLaparoskopisk kirurgi | Mavekræft | Gastrectomi | LymfadenektomiKina
-
Peking University Cancer Hospital & InstituteAfsluttetKræftpatienter | FunktionsforlængelseKina
-
Peking University Cancer Hospital & InstituteAfsluttet
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterendeKræftrelateret problem/tilstandKina
-
Peking University Cancer Hospital & InstituteAfsluttetMetastatisk lungekræftKina
-
Peking University Cancer Hospital & InstituteAfsluttetSpiserørskræftKina
-
Peking University Cancer Hospital & InstituteAfsluttet
-
Peking University Cancer Hospital & InstituteUkendtMR scanning | Positron-emissionstomografiKina
-
Peking University Cancer Hospital & InstituteUkendtHepatocellulært karcinom | Transarteriel kemoembolisering
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteAfsluttetKræftrelateret problem/tilstand
-
Peking University Cancer Hospital & InstituteUkendtMavekræft | Gastroøsofageal cancer
-
Peking University Cancer Hospital & InstituteUkendtNeoplasmer i leverenKina
-
Peking University Cancer Hospital & InstituteUkendtGastrointestinale neoplasmerKina
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtLymfom, stor B-celle, diffusKina
-
Peking University Cancer Hospital & InstituteUkendtGastrointestinal stromal tumorKina
-
Peking University Cancer Hospital & InstituteAfsluttet
-
Peking University Cancer Hospital & InstituteAfsluttetBrystneoplasmer | Neoplasma Metastase | Immunterapi | GenekspressionsprofileringKina
-
Peking University Cancer Hospital & InstituteUkendtGastrointestinale neoplasmerKina
-
Peking University Cancer Hospital & InstituteAfsluttetBrystneoplasmer | Neoplasma MetastaseKina
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuMelanom | Metastatisk melanom | Slimhinde melanomKina
-
Peking University Cancer Hospital & InstituteRekrutteringRecidiverende/refraktær B-celle non-Hodgkin lymfomKina
-
Peking University Cancer Hospital & InstituteRekrutteringKræft i fordøjelsessystemetKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuMetastatisk kastrationsresistent prostatakræft
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringFase 2-undersøgelse af SBRT Plus Tislelizumab og Regorafenib i uoperabelt eller oligometastatisk HCCIkke-operabelt hepatocellulært karcinom | Oligometastatisk sygdomKina
-
Peking University Cancer Hospital & InstituteRekrutteringKolorektal cancer | LungekræftKina
-
Peking University Cancer Hospital & InstituteRekrutteringIkke-småcellet lungekræft | Konsoliderende immunterapi | Strålebehandling eller sekventiel kemoradiationKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuCOVID-19 | Kirurgi-komplikationerKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuBlødt vævssarkom
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringMelanom | Temozolomid | Apatinib | Camrelizumab | Akralt melanom | Neoadjuvans | Patologisk responsKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekrutteringAvanceret melanomKina
-
Peking University Cancer Hospital & InstituteRekrutteringMelanom | Lungekræft | PD-L1 | PET/CTKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringKolorektal cancer | Positron-emissionstomografi | Tumor, fastKina